Background This study aimed to research the association between your usage of selective serotonin reuptake inhibitors (SSRIs) and the chance of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. 1.28 and 3.51 per 1000 person-years for SSRI and non-SSRI users, respectively. After changing for potential confounders, the altered hazard proportion (HR)… Continue reading Background This study aimed to research the association between your usage